Eindhoven, Netherlands

Zarko Aleksovski

This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2016-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zarko Aleksovski. Retrieved from https://idiyas.com/inventor/zarko-aleksovski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Zarko Aleksovski - Innovative Inventor from Eindhoven

Introduction: Zarko Aleksovski is a renowned inventor based in Eindhoven, Netherlands, known for his groundbreaking contributions to various technological fields.

Latest Patents: Zarko Aleksovski holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, Zarko Aleksovski has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of technology.

Collaborations: Throughout his career, Zarko Aleksovski has collaborated with top engineers, scientists, and designers from around the globe, fostering a culture of innovation and creativity in all his projects.

Conclusion: Zarko Aleksovski's passion for innovation and his relentless drive to create a better future through technology make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…